This has been a bad year for Biogen (NASDAQ:BIIB) so far -- the biotech's stock has dropped more than 10% since it began. But 2018 has been horrible for Acadia …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
Key highlights this week include the announcement of a couple of acquisition agreements as well as pipeline news from Biogen BIIB and Celgene CELG. The M&A announcements relate to the acquisition of Ignyta RXDX by Roche and …
Yahoo!4mon
Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. But in the past few days of trading, it gave back about one-third of it. Source: Biogen via YouTube Clearly, this is a momentum stock, so it will never give us …
The earnings cycle is sending some mixed signals for the first time this quarter as three more widely watched stocks …